AZN vs HROW · P/E 28, $288.38B cap vs rev $114.9M
AstraZeneca PLC (AZN) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. HROW currently screens at market cap $1.28B.
Not investment advice. Open the AZN and HROW stock pages for the full models.
Not investment advice.